Integrin α <sub>v</sub> β <sub>3</sub> as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter <sup>68</sup> Ga-Labeled DOTA-Arginine-Glycine-Aspartic Acid (RGD) Ligand
Rakhee Vatsa(Post Graduate Institute of Medical Education and Research), Bhagwant Rai Mittal(Government of Haryana), Sudipta Chakraborty, Gurpreet Singh(Post Graduate Institute of Medical Education and Research), Ashutosh Dash(Bhabha Atomic Research Centre), Jaya Shukla(Rutgers, The State University of New Jersey), Priya Bhusari(Post Graduate Institute of Medical Education and Research), D. K. Dhawan(Panjab University)
Cited by 13
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Antimicrobial Stewardship Programs in Resource Constrained Environments: Understanding and Addressing the Need of the Systems
|Frontiers in Public Health|2020|134
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117